Introduction and evaluation of Bayesian adaptive randomization in clinical trialsCHEN Dong, XIA Jie-lai, JIANG Zhi-wei, WANG Yong-ji706-709
Current situation and development of the quality standard research of traditional Chinese medicineXIN Min-tong, LI Zheng, GUO Hong-zhu, DONG Run-sheng, WANG Zhi-bin710-713
Measurement and transformation of utilities for health states worse than deathWU Hong-yan, SUN Li-hua714-717
Regulatory perspective on the importance of safety pharmacology study before clinical trial of new drugsWANG Yu-zhu, WANG Qing-li718-721
Introducing internationally recognized management method in Chinese clinical trial institutionWANG Tian-xun, MAO Yi-min, GONG Yan-hua, LIANG Wen-juan728-731
Simultaneous determination of ascaridole ,p-cymene and α-terpinene in Jinghua Weikang Jiaowan by GCZHU Yong-hong, LI Wei, HAN Jian-ping, CHU Yang, WANG Xiang-yang737-739
In vitro anti-HIV-1 activities of resveratrol derivativesHAUNG Ning, YANG Liu-meng, WANG Rui-rui, ZHU Hai-liang, ZHENG Yong-tang740-745
Preliminary analysis of cytokine-release syndrome induced by monoclonal antibodiesLIN Zhi, L(U) Jian-jun, QU Zhe, GENG Xing-chao, YANG Yan-wei, ZHANG Di, LI Shan-shan, LI Bo746-750,756